Montana Becomes the Right to Try Anything State, Expanding Access to Experimental Drugs

Montana is poised to become a national model for experimental medical treatments with a new bill allowing access to drugs beyond Phase I trials, including for non-terminally ill patients. Advocates see this as a hub for cutting-edge therapies like gene therapy and anti-aging drugs, potentially funneling funding locally. However, ethicists warn that the small sample sizes of Phase I trials often miss serious side effects, with over 90% of experimental drugs failing safety checks before approval. The debate hinges on balancing access with patient safety.